Key regions: Australia, Italy, France, South Korea, Brazil
The demand for vaccines in Moldova has been steadily increasing over the years.
Customer preferences: Moldova has a population of approximately 2.6 million people, and the majority of the population prefers to receive vaccinations from public healthcare facilities. However, there is a growing trend of people opting for private healthcare facilities for vaccinations due to the convenience and accessibility they offer. Additionally, there is a growing awareness of the importance of vaccines among the population, which has led to an increase in demand for vaccines.
Trends in the market: The vaccines market in Moldova has been growing steadily over the years, with an increasing number of vaccines being introduced into the market. The most commonly administered vaccines in Moldova include the influenza vaccine, hepatitis B vaccine, and the human papillomavirus (HPV) vaccine. There has also been a growing demand for vaccines for diseases such as measles, mumps, and rubella, which have seen an increase in cases in recent years. The COVID-19 pandemic has also led to an increased demand for vaccines, with the government launching a vaccination campaign to vaccinate the population.
Local special circumstances: Moldova is a low-income country, and the government provides free vaccinations to the population through public healthcare facilities. However, the public healthcare system faces challenges such as a lack of resources, which has led to a shortage of vaccines in some areas. Additionally, there is a lack of awareness among the population about the importance of vaccines, which has led to a low vaccination rate in some areas.
Underlying macroeconomic factors: Moldova's economy has been growing in recent years, with an increasing number of people having access to healthcare. However, the country still faces challenges such as a lack of resources and infrastructure in the healthcare sector. The government has been working to improve the healthcare system by investing in infrastructure and increasing the availability of resources. Additionally, the country has been receiving support from international organizations to improve healthcare in the country. These factors have contributed to the growth of the vaccines market in Moldova.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
